期刊文献+

Maspin和MMP-2在乳腺浸润性导管癌中的表达及其临床意义 被引量:5

Expression and clinical significance of Maspin and MMP-2 in breast infiltrative ductal carcinoma
下载PDF
导出
摘要 目的探讨Maspin和MMP-2在乳腺浸润性导管癌组织中的表达及意义。方法应用免疫组织化学SP法检测60例乳腺浸润性导管癌及20例正常乳腺组织中Maspin和MMP-2的表达。结果Maspin在乳腺浸润性导管癌中表达阳性率为45.0%,低于在正常乳腺组织中的表达阳性率95.0%(P<0.05);MMP-2在乳腺浸润性导管癌中表达阳性率为75.0%,高于在正常乳腺组织中的表达阳性率15.0%(P<0.05)。Maspin和MMP-2的表达均与乳腺浸润性导管癌的淋巴结转移相关(P<0.05),MMP-2的表达还与乳腺浸润性导管癌临床分期相关(P<0.05)。乳腺浸润性导管癌中Maspin与MMP-2的表达呈负相关(r=-0.11,P<0.05)。结论 Maspin对乳腺浸润性导管癌的转移有抑制作用,MMP-2对乳腺浸润性导管癌的转移有促进作用,检测Maspin和MMP-2的表达可以成为判断乳腺浸润性导管癌浸润及转移能力的重要指标之一。 Objective To investigate the expression and clinical significance of Maspin and MMP-2 in breast infiltrative ductal carcinoma. Methods The expression of Maspin and MMP-2 were detected by immunohistochemical staining( streptavidine-peroxidase method)in 60 cases of breast infiltrative ductal carcinoma and 20 cases of normal breast tissues. Results The expression rate of Maspin in invasive ductal carcinoma of breast was significantly lower than that in normal breast tissues(45.0% vs. 95.0% ,P 〈 0.05 ). The expression rate of MMP-2 in invasive ductal carcinoma of breast was significantly higher than that in normal breast tissues ( 75.0% vs. 15.0%, P 〈 0.05 ). Maspin and MMP-2 expression were associated with lymph node metastasis ( P 〈 0.05 ). MMP-2 expression was associated with clinical stages ( P 〈 0.05). The expressions of Maspin and MMP- 2 were not closely related in breast infiltrative ductal carcinoma(r = - 0.1 i, P 〈 0.05 ). Conclusions Maspin protein can inhibit the metastasis in breast infiltrative duetal carcinoma ;while MMP-2 may stimulate the infiltration and metastasis in breast infiltrative ductal carcinoma. Joint detection of Maspin and MMP-2 may become a new assistant index for detecting the infiltration and metastasis of breast infiltrative ductal carcinoma.
出处 《中国肿瘤外科杂志》 CAS 2014年第4期225-229,共5页 Chinese Journal of Surgical Oncology
关键词 乳腺癌 MASPIN MMP-2 表达 免疫组织化学 breast carcinoma Maspin MMP-2 expression immunohistochemistry
  • 相关文献

参考文献2

二级参考文献37

  • 1Davidson B,Givant-Horwitz V,Lazarovici P,et al.Matrix metalloproteinases (MMP),EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK):co-expression in metastatic serous ovarian carcinoma[J].Clin Exp Metastasis,2003,20(7):621-631.
  • 2Van Trappen PO,Ryan A,Carroll M,et al.A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer[J].Br J Cancer,2002,87(5):537-544.
  • 3Bhuvarahamurthy V,Kristiansen GO,Johannsen M,et al.In situ gene expression and localization of metalloproteinases MMP1,MMP2,MMP3,MMP9,and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma[J].Oncol Rep,2006,15(5):1379-1384.
  • 4Hanemaaijer R,Verheijen JH,Maguire TM,et al.Increased gelatinase-A and gelatinase-B activities in malignant vs.benign breast tumors[J].Int J Cancer,2000,86(2):204-207.
  • 5Li HC,Cao DC,Liu Y,et al.Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma[J].Breast Cancer Res Treat,2004,88(1):75-85.
  • 6Budihardjo I;Oliver H;Lutter M.Biochemical pathways of caspase activation during apoptosis,1999.
  • 7Lüttges,J,Zamboni,G,Longnecker,D,Kl?ppel,G.The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. The American Journal of Surgical Pathology . 2001
  • 8Masanao Nakashima,Nobuyuki Ohike,Koichi Nagasaki,Mitsuru Adachi,Toshio Morohoshi.Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma[J]. Journal of Cancer Research and Clinical Oncology . 2004 (8)
  • 9Suguru Yonezawa,Akiko Nakamura,Michiko Horinouchi,Eiichi Sato.The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms[J]. Journal of Hepato - Biliary - Pancreatic Surgery . 2002 (3)
  • 10Sang Yong Song,Se Kyung Lee,Duck Hwan Kim,Hee Jung Son,Hong Joo Kim,Yun Jeong Lim,Woo Yong Lee,Ho-Kyung Chun,Jong Chul Rhee.Expression of Maspin in Colon Cancers: Its Relationship with p53 Expression and Microvessel Density[J]. Digestive Diseases and Sciences . 2002 (8)

共引文献14

同被引文献55

  • 1冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 2Nicoloso MS,Spizzo R,Shimizu M,et al.MicroRNAs-the micro steering wheel of tumor metastases[J].Nat Rev Cancer,2009,9(4):293-302.
  • 3Sopel M,Surowiak P,Berdowska I.Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma[J].Folia Morphol(Warsz),2010,69(4):204-212.
  • 4Coticchia CM,Curatolo AS,Zurakowski D,et al.Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels[J].Gynecol Oncol,2011,123(2):295-300.
  • 5Jemal A,Siegel R,Ward E,et al.Cancer statistics.CA Cancer J Clin,2009,59:225-249.
  • 6Brnardo MM,Meng Y,Lockett J,et al.Maspin Reprograms the Gene Expression Profile of Prostate Carcinoma cells for Differentiation.Genes Cancer,2011,2:1009-1022.
  • 7Sopel M,Surowial P,Berdowskal I.Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.Folia Morpol(Warsz),2010,69:204-212.
  • 8Yitorng T,Huiw PO,Hsiuting T,et al.Genetic Polymorphism of U rokinase-Type Plasm inogen activator is Interaceing with plasm inogen activator inhibitor-1 to raise risk of cervical neoplasia.J Surgic Oncol,2012,106:204-208.
  • 9Larap C,L loret M,Valenciano A,et al.Plasm inogen activator inhibitor-1(PAL-1)expression in relation to hypoxia and oncoproteins in clinical cervical tumor.Strahlenther Onkol,2012,188:1139-1145.
  • 10Ren F,Shih R,Zhang G,et al.Expression of deleted in liver cancer 1and plasm inogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance.J Exp Clin Cancer Res,2013,32:60-67.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部